Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 144 citing articles:

Neuropathology of Alzheimer's Disease
Jorge Trejo‐Lopez, Anthony T. Yachnis, Stefan Prokop
Neurotherapeutics (2021) Vol. 19, Iss. 1, pp. 173-185
Open Access | Times Cited: 225
Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg?
Elena Tamagno, Michela Guglielmotto, Valeria Vasciaveo, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1479-1479
Open Access | Times Cited: 149
Amyloidosis in Alzheimer’s Disease: Pathogeny, Etiology, and Related Therapeutic Directions
Chen Ma, Fen‐Fang Hong, Shu‐Long Yang
Molecules (2022) Vol. 27, Iss. 4, pp. 1210-1210
Open Access | Times Cited: 124
Tau-targeting therapies for Alzheimer disease: current status and future directions
Erin E. Congdon, Changyi Ji, Amber M. Tetlow, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 715-736
Closed Access | Times Cited: 122
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 119
Oxidative Stress Occurs Prior to Amyloid Aβ Plaque Formation and Tau Phosphorylation in Alzheimer’s Disease: Role of Glutathione and Metal Ions
Rimil Guha Roy, Pravat K. Mandal, Joseph C. Maroon
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 17, pp. 2944-2954
Open Access | Times Cited: 76
Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality
Zhenyi Hu, Po‐Han Chen, Wenxue Li, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 7, pp. 4045-4055
Closed Access | Times Cited: 52
Disentangling tau: One protein, many therapeutic approaches
Courtney Lane‐Donovan, Adam L. Boxer
Neurotherapeutics (2024) Vol. 21, Iss. 2, pp. e00321-e00321
Open Access | Times Cited: 18
p-tau Ser356 is associated with Alzheimer’s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003
Lewis W. Taylor, Elizabeth Simzer, Claire Pimblett, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 16
Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
Vanesa R. Hyde, Chaoming Zhou, J R Muñóz y Fernández, et al.
Cell Reports (2025), pp. 115109-115109
Open Access | Times Cited: 9
The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death
Dietmar Rudolf Thal, Sandra O. Tomé
Brain Research Bulletin (2022) Vol. 190, pp. 204-217
Open Access | Times Cited: 49
Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors
Liwen Hua, Qiuyue Zhang, Xinyue Zhu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8091-8112
Closed Access | Times Cited: 48
Lost in traffic: consequences of altered palmitoylation in neurodegeneration
Firyal Ramzan, Fatima Abrar, Gyana Gourab Mishra, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 24
Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition
Joshua Limantoro, Bryan Gervais de Liyis, Jane Carissa Sutedja
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2023) Vol. 59, Iss. 1
Open Access | Times Cited: 23
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Enjie Liu, Yao Zhang, Jian–Zhi Wang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease
Tao Zhang, Byeong Mo Kim, Tae Ho Lee
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Tau protein profiling in tauopathies: a human brain study
Juan Lantero Rodrı́guez, Elena Camporesi, Laia Montoliu‐Gaya, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders
Banglian Hu, Shengshun Duan, Ziwei Wang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 53
β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer’s disease and predicts cerebral amyloidosis
Taoran Li, Yunxia Yao, Xueyan Jiang, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 32
Phosphorylation of Tau R2 Repeat Destabilizes Its Binding to Microtubules: A Molecular Dynamics Simulation Study
Viet Hoang Man, Xibing He, Jie Gao, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 458-467
Open Access | Times Cited: 20
Nature's toolbox against tau aggregation: An updated review of current research
Sumaiya Khan, Md. Imtaiyaz Hassan, Mohammad Shahid, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101924-101924
Closed Access | Times Cited: 20
The role of glycogen synthase kinase 3 beta in neurodegenerative diseases
Honglu Yu, Min Xiong, Zhentao Zhang
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 20
Vibrotactile stimulation at gamma frequency mitigates pathology related to neurodegeneration and improves motor function
Ho‐Jun Suk, Nicole Buie, Guojie Xu, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 19
Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer’s Disease
Débora A. Moreira, Sofia Duque Santos, Victoria Leiro, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1054-1054
Open Access | Times Cited: 17
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
Xingyu Zhang, Jiangyu Wang, Zhentao Zhang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top